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Abstract
Trefoil factor 1 (TFF1) belongs to a family of secreted peptides with a characteristic tree-looped trefoil structure. TFFs
are mainly expressed in the gastrointestinal tract where they play a critical role in the function of the mucosal barrier.
TFF1 has been suggested as a neuropeptide, but not much is known about its expression and function in the central
nervous system. We investigated the expression of TFF1 in the developing and adult rat midbrain. In the adult ventral
mesencephalon, TFF1-immunoreactive (-ir) cells were predominantly found in the substantia nigra pars compacta
(SNc), the ventral tegmental area (VTA) and in periaqueductal areas. While around 90% of the TFF1-ir cells in the
SNc co-expressed tyrosine hydroxylase (TH), only a subpopulation of the TH-ir neurons expressed TFF1. Some
TFF1-ir cells in the SNc co-expressed the calcium-binding proteins calbindin or calretinin and nearly all were NeuN-ir
confirming a neuronal phenotype, which was supported by lack of co-localization with the astroglial marker glial
fibrillary acidic protein (GFAP). Interestingly, at postnatal (P) day 7 and P14, a significantly higher proportion of TH-ir
neurons in the SNc co-expressed TFF1 as compared to P21. In contrast, the proportion of TFF1-ir cells expressing
TH remained unchanged during postnatal development. Furthermore, significantly more TH-ir neurons expressed
TFF1 in the SNc, compared to the VTA at all four time-points investigated. Injection of the tracer fluorogold into the
striatum of adult rats resulted in retrograde labeling of several TFF1 expressing cells in the SNc showing that a
significant fraction of the TFF1-ir cells were projection neurons. This was also reflected by unilateral loss of TFF1-ir
cells in SNc of 6-hydroxylase-lesioned hemiparkinsonian rats. In conclusion, we show for the first time that distinct
subpopulations of midbrain dopaminergic neurons express TFF1, and that this expression pattern is altered in a rat
model of Parkinson’s disease.
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Introduction
Idiopathic Parkinson’s disease (PD) is a common
neurodegenerative disorder characterized by progressive loss
of dopaminergic neurons in substantia nigra pars compacta
(SNc) within the ventral mesencephalon. The resulting
dopamine depletion leads to an imbalance in the nigrostriatal
circuitry causing serious motor dysfunction [1,2]. Cardinal
motor symptoms include resting tremor, muscle rigidity,
bradykinesia, akinesia, and postural instability. However, non-
motor symptoms are also present, these include depression,
dementia, sleep disturbances and autonomic dysfunction [3].
Despite major efforts, the cause of the selective loss of
dopaminergic neurons remains largely unknown, although
several mechanisms have been proposed including oxidative
stress, mitochondrial dysfunction and, excitotoxic damage [4].
Thus, more knowledge on the developmental biology of
midbrain dopaminergic neurons, as well as molecules and
mechanisms potentially taking part in the pathophysiology of
PD, is clearly needed.
Midbrain dopaminergic neurons represent a heterogeneous
cell population that can be divided into three principal groups;
those of the the retrorubral area, SNc and the ventral tegmental
area (VTA), also classified as the A8, A9 and A10 cell groups,
respectively [5]. Besides being present in distinct locations,
these dopaminergic neurons display characteristic projections.
The A9 neurons of the SNc primarily innervate the dorsal
striatum generating the nigrostriatal pathway, which is affected
in PD. The A10 cell group mainly innervate ventral striatal and
limbic areas as well as the frontal cortex and are relatively
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spared in PD, whereas the A8 cell group appears mainly to be
involved in the interconnection of the SN and VTA [6,7].
Various criteria have been used to identify subtypes of
neurons within these cell groups, including morphological
differences and differences expression of the calcium-binding
proteins calbindin (CB), calretinin (CR) and parvalbumin (PV)
[8–11]. The SNc and VTA can thus be divided into
subcompartments based on the distribution of dopaminergic
cell populations expressing CR and/or CB. PV is mostly
restricted to the ventral SN pars reticulata, which contains
predominantly GABAergic neurons [10,12]. CR and CB show a
distinct pattern of expression during development. The CR-
immunoreactive (-ir) cells appear relatively early in the rostral
SN, and are thereafter distributed throughout the SNc and VTA
- most prominently in the ventral tier. CB-ir cells develop later
and are particularly abundant in the VTA and dorsal tier of the
SNc [13]. The functional significance of this
compartmentalization remains unknown. Calcium-binding
proteins are believed to regulate cellular activities such as cell
proliferation, migration, and differentiation by suppressing or
buffering intracellular calcium [14,15]. Notably, it has been
shown that both CB-ir and CR-ir cells are more resistant to
damage caused by PD and toxic insults than other nigral cells
[16–19].
Trefoil factor 1 (TFF1) belongs to a peptide family (TFF1-3)
most distinctly expressed in the gastrointestinal tract, where the
peptides play essential roles in the function of the mucosal
protective barrier. TFF peptides contain one or more
characteristic trefoil domains, defined as a sequence of 42 or
43 amino acid residues in which 6 cysteines are disulphide-
linked and form a characteristic three-leaved structure [20].
TFF peptides have been shown to influence precursor cell
migration and epithelial restitution in the gastrointestinal tract
and to protect cells against apoptosis [21]. All TFF peptides are
synthesized via precursors containing a cleavable N-terminal
sequence characteristic of secretory proteins [22]. Whilst no
TFF receptors have yet been identified, receptor-ligand modes
of action have been suggested [23,24]. TFF1 was first
discovered in a human breast cancer cell line [25] and later
shown to stimulate migration of breast cancer cells [26].
Several studies have shown that TFFs act as neuropeptides
expressed in certain areas of the central nervous system
(CNS), but the specific cellular expression and function of TFF1
remain largely unknown. In 1995, Hirota et al. reported that
TFF1 mRNA was strongly expressed in rat hippocampus and
moderately expressed in frontal cortex and cerebellum.
Hippocampal TFF1 synthesis was found to peak around birth
and then gradually decline from postnatal (P) day 7. Moreover,
astrocytes were reported to represent the major site of TFF1
mRNA synthesis [27]. In accordance, expression of TFF1
mRNA in cultured mouse astrocytes has been found in the late
G1 or early S phase under regulation of cytokines, such as
IL-6, IL-7, and TNF-α [28,29]. However, these studies only
address TFF1 mRNA levels by semi-quantitative PCR and
have never been followed by more thorough data showing
protein expression levels. Moreover, Hinz et al. analyzed the
mRNA expression of TFF peptides in the mouse brain and
found that TFF1 was expressed in many brain regions to
varying extents, while TFF2 was predominantly found in the
anterior pituitary. In contrast, TFF3 expression was limited to
the hippocampus, the temporal cortex and the cerebellum, and
TFF3 mRNA appeared to be restricted mainly to neurons [30].
Interestingly, Kriks et al. recently found highly enriched TFF3
mRNA levels in human embryonic stem cell cultures committed
towards midbrain dopaminergic neurons as compared to
cultures stimulated in a forebrain direction [31]. Any functional
significance of this finding remains to be elucidated.
Tools to identify and distinguish subpopulations of midbrain
dopaminergic neurons may provide new information on the
specific cells that degenerate in PD and hence facilitate our
understanding of the underlying disease mechanisms.
With the aim to test TFF1 as a potential supplementary
marker of subsets of midbrain dopaminergic neurons we here
investigated its expression in the developing and adult rat
ventral mesencephalon by means of immunohistochemistry
and retrograde tracing of nigrostriatal fibers. In addition, we
studied the effects of unilateral, 6-hydroxydopamine (6-OHDA)
lesions on the content and distribution of midbrain TFF1-ir
cells.
Experimental Procedures
Animals and tissue processing
This study was carried out in strict accordance with the
recommendations in the Law for the Care and Use of
Laboratory Animals of the Swiss Authorities (BVET). The
procedures were approved by the Animal Research Ethics
Committee of the Canton Berne, Switzerland (Permit Numbers:
89/05, 6/12). All surgeries were performed under appropriate
anaesthesia, and all efforts were made to minimize suffering of
the animals (see below).
Under deep surgical anaesthesia (Ketamine 100mg/kg and
Xylazine 10mg/kg) adult female Wistar rats (Janvier Elevage,
France) were perfused through the ascending aorta using a
perfusion pump, first with a prewash solution of 200 ml 0.1M
PBS followed by 400 ml fixative (4% paraformaldehyde (PFA)
in 0.1M PBS, pH 7.3). For that purpose the thorax was opened
by a transdiaphragmal approach and heparin was administered
intracardially (1000 I.E. /100 ml, Novo Nordisk, Denmark). To
avoid perfusion of the whole body, the descending aorta was
pinched off with a clamp. The rats were decapitated
immediately after perfusion and the brains removed carefully
from the skull. Post fixation was performed in 4% PFA/PBS (pH
7.3) for six hours and thereafter the brains were cryoprotected
by immersion in PBS containing 10% sucrose and 0.01%
NaN3. After freezing in isopentane at -80°C the brains were cut
on a cryostat (Leica, AM1900) at 30 µm. The sections were
mounted either directly on silane-coated superfrost microscope
slides or stored in wells with anti-freeze solution (400 ml H2O,
300 ml glycerol, 300 ml ethylenglycol, 1.57 g NaH2PO4 and
5.18 g Na2HPO4) at -20°C. The brains were cut in series of six.
Three sections were mounted on slides and three were stored
as free-floating sections in wells. Each slide or well contained
three sections that were 180 µm apart, thus covering a range of
360 µm.
Expression of Trefoil Factor 1 in Dopamine Cells
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Adult rat stomach tissue was collected for control
immunohistochemical stainings. Briefly, the stomach was
removed from deeply CO2-anaesthetized rats according to local
and national animal ethics regulations. Stomachs were
depleted from content by washing in D-PBS followed by
immersion fixation in 4% PFA/PBS for six hours, and thereafter
the tissue was cryoprotected in PBS containing 20% sucrose
for at least 24 hours at 4°C. After, tissue was frozen using
gaseous CO2 followed by cryostat sectioning at 30 µm and
mounting on superfrost microscope slides.
Unilateral 6-hydroxydopamine (6-OHDA)-lesions
Female Wistar rats (Janvier Elevage, France), weighing
220-250g were briefly sedated with isoflurane (75% N2O, 20%
O2, 4.5-5% Isoflurane) before receiving an injection of
Ketamine and Xylazine (Ketamine 75mg/kg and Xylazine
5mg/kg) and being placed in a stereotaxic frame (Kopf
Instruments, USA). Prior to the incision, a subcutaneous
injection of lidocaine HCl (1%) was administered. Striatal
dopamine depletions were made by injection of 32 mM 6-
OHDA hydrobromide (Sigma) in 4 µl saline supplemented with
0.02% ascorbic acid as an antioxidant into the right striatum
through a small burrhole in the skull. The injection was
performed over 6 min using a 10 µl Hamilton microsyringe. The
injection rate was 1 µl/min. The syringe was left in place for an
additional 4 min before removal [32]. The following coordinates
in relation to Bregma were used: posterior 1.0 mm, lateral 3.0
mm and ventral -5.0 mm to the dura, the incisor bar was set at
0.0 mm [33]. Animals received a subcutaneous injection of
Carprofen (5 mg/kg) as postoperative analgesic. After 4 weeks
rats were perfused as described above.
Fluorogold injection
Fluorogold is a reliable tracer for retrograde labelling of
neurons [34]. Female Wistar rats (Janvier Elevage, France),
weighing 220-250g were briefly sedated with isoflurane (75%
N2O, 20% O2, 4.5-5% Isoflurane) followed by an injection of
Ketamine and Xylazine (Ketamine 75mg/kg and Xylazine
5mg/kg) and placed in a stereotaxic frame (Kopf Instruments,
USA). Prior to the incision, a subcutaneous injection of
lidocaine HCl 1% was administered. 0.2 µl of 2% Fluorogold
(Chemicon) in 0.9% NaCl was injected into the right striatum
through a small burrhole created in the skull. Fluorogold was
injected over 5 minutes using a 1 µl Hamilton needle. The
needle was left in place for another 8 minutes and removed.
The following coordinates in relation to Bregma were used:
posterior 1.0 mm, lateral 3.0 mm and ventral -4.5 mm to the
dura, the incisor bar was set at 0.0 mm [35]. Animals received
a subcutaneous injection of Carprofen (5 mg/kg) as
postoperative analgesic. After a survival time of 10 days, the
animals were re-anesthetized and perfused as described
above.
Immunohistochemistry
Free-floating sections were washed four times in 0.1M PBS
to remove the anti-freeze solution. Mounted sections were
rinsed in PBS for 15 min. All sections were pre-incubated with
PBS containing 0.4% Triton X-100 and 10% horse serum for 2
hours at room temperature. After a brief wash in PBS, sections
were incubated with primary antibodies (rabbit anti-TFF1,
1:1000, Novocastra; rabbit anti-TH, 1:1000, Pelfreeze) diluted
in PBS containing 0.1% Triton X-100 and 2.5% horse serum
overnight at 4°C. Subsequently, sections were incubated with a
secondary antibody solution consisting of biotinylated horse
anti-rabbit or goat anti-mouse antibody (Vector laboratories)
diluted 1:200 in PBS containing 0.1% Triton X-100 and 2.5%
horse serum for 2 hours at room temperature. After washing for
4x10 min in PBS endogenous peroxidase was blocked by
treating the sections with PBS containing 3.6% H2O2 and 10%
methanol, followed by 3x10 min washes in PBS. Visualization
of cell bound antibodies was performed using the avidin-
peroxidase-complex system (Vector Laboratories) combined
with a 3,3’-diaminobenzidine (DAB) substrate kit (Pierce). After
2x5 min wash in PBS the free-floating sections were mounted
carefully on poly-L-lysine-coated slides with a brush and air-
dried for an hour. All sections were dehydrated in graded
ethanol (70%, 95%, 100%) for 3 min each, cleared in xylene
and cover slipped with Eukitt mounting medium.
Negative control staining was performed by omitting either
primary or secondary antibodies. Positive controls were
performed by TFF1 immunostaining of rat stomach/intestinal
tissue (Figure S1). To identify the optimal working
concentration of the anti-TFF1 antibody, immunostaining was
performed using dilutions of 1:250, 1:500 and 1:2000. Each
dilution resulted in staining of cells in the SN (Figure S2).
Notably, dilutions of 1:250 and 1:500 caused a rather strong
background staining. In contrast, the 1:2000 dilution resulted in
a weak background staining but also a weaker staining pattern.
Hence, we decided to use a dilution of 1:1000 in all the
following experiments.
To further verify our initial findings and evaluate antibody
specificity, adjacent brain sections were immunostained using
a monoclonal mouse anti-TFF1 antibody (anti-pS2, Clone
BC04, Zymed Lab.) and the staining pattern compared with
that of the antibody used in this study (rabbit polyclonal NCL-
pS2, Novocastra, Leica Microsystems). Similar staining
patterns were observed for the two antibodies as shown at the
level of the subfornical organ and in the midbrain of adult rats
(Figure S3). However, the monoclonal antibody resulted in a
weaker staining pattern even after antigen retrieval. Unilateral
lesion of TH-ir positive cells in the SNc of the 6-OHDA rat
model of PD [32] resulted in partial depletion of TFF1-positive
cells as detected by use of both antibodies (Figure S4).
Hence, the rabbit polyclonal anti-TFF1 was used throughout
the present study.
Immunofluorescence staining
Double immunofluorescence stainings were performed as
described above with minor additions. Briefly, sections were
incubated with a mixture of rabbit anti-TFF1 (1:500,
Novocastra) and mouse anti-TH (1:1000, Chemicon), mouse
anti-neuronal nuclei (NeuN) (1:100, Chemicon), mouse anti-
glial fibrillary acidic protein (GFAP) (1:400, Chemicon), mouse
anti-MAB1580 (1:1000, Chemicon), mouse anti-calbindin (CB)
(1:2000, Swant), mouse anti-parvalbumin (PV) (1:2000, Swant)
or mouse anti-calretinin (CR) (1:2000, Swant) diluted in PBS
Expression of Trefoil Factor 1 in Dopamine Cells
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containing 0.1% Triton X-100 and 2.5% horse serum overnight
at 4°C. Subsequently, sections were incubated with a mixture
of Alexa Fluor® 488 conjugated donkey anti-mouse IgG and
Alexa Fluor® 594 conjugated donkey anti-rabbit IgG (1:250,
Molecular Probes) for 2 hours at room temperature. Cell nuclei
were counterstained with Hoechst 33342 (Invitrogen, Molecular
Probes) at 1:10,000. Finally, free-floating sections were
mounted on poly-lysine-coated slides with a brush and air-dried
for an hour in the dark. Sections were cover-slipped with PBS
containing 50% glycerol (Merck) and examined using a digital
camera (Nikon) equipped epifluorescence microscope (Leitz).
Images were processed using Adobe® Photoshop® software.
Cell counting and statistical analyses
Semi-quantitative analysis of midbrain TFF1-ir cells was
performed on sections from 3 different control animals at the
level: Bregma -5.8 mm. Sections were analyzed on a
microscope (Olympus BX51) equipped with a digital camera
(Olympus DP72). Pictures were taken at 100x magnification
and stitched together to keep track of the brain areas and to
have a sufficient resolution to distinguish single cells. A grid
(200 µm x 200 µm) was overlaid, and TFF1-ir cells were
counted in each square using the cell counting tool of CellF©
(Olympus).
Quantitative analyses of TH and TFF1 co-localizing cells in
the SN and VTA of P7, P14, P21 and adult rats were
performed on fluorescent pictures taken at 100x magnification
on a Leitz epifluorescence microscope equipped with a Nikon
digital camera. The areas of SN and VTA were verified by the
use of consecutive sections stained for TH using DAB as
described above. Four to seven animals were used per time
point with three to six brain sections used from each animal,
and cell counts were performed on both sides of the brain. TH-
ir and TFF1-ir cells were counted on single
immunofluorescence pictures and subsequently the co-
localizing cells were counted on pictures of double
immunofluorescence-stained sections using Adobe®
Photoshop® software.
Statistical analyses of cell densities were performed by
means of commercially available software (Instat, GraphPad
Software). Relative contents of TH/TFF1 or TFF1/TH co-
expressing cells during development were compared using
parametric one-way analysis of variance (ANOVA) followed by
Student-Newman-Keuls multiple comparisons. The ratios of
TH-ir cells expressing TFF1 and of TFF1-ir cells expressing TH
in SN and VTA in adult rats were compared using a two-sided
Fisher’s exact test. Differences were considered statistically
significant at P<0.05. Values are presented as mean ± SEM.
Results
Expression of TFF1 in the adult rat ventral
mesencephalon
Immunohistochemical analyses of adult rat mesencephalic
brain sections revealed that TFF1 was expressed throughout
the midbrain, with the most pronounced expression in the
substantia nigra (SN), the periaqueductal grey matter and the
Edinger-Westphal nucleus. The distribution pattern of TFF1-ir
cells in the midbrain is schematically summarized in Figure 1.
In the ventral midbrain TFF1 was markedly expressed in cells
of the SN pars compacta (SNc) and the SN pars lateralis (SNl),
and to a lesser extent in the ventral tegmental area (VTA),
while SN pars reticulata (SNr) contained almost no TFF1-ir
cells (Figure 2).
Quantification of the relative content of TFF1-ir cells that co-
localized with TH revealed no significant difference between
the SN and VTA (Figure 3A) (SN: 89.6 ± 0.9 and VTA: 80.2 ±
5.0% TFF1 co-localization with TH; mean ± SEM; n = 4),
whereas the percentage of TH-ir cells that co-localized with
TFF1 was significantly higher in the SN as compared to the
VTA (Figure 3B) (SN: 26.8 ± 1.5 and VTA: 13.1 ± 1.2% TH co-
localization with TFF1; mean ± SEM; n = 4; P<0.05).
Antibody specificity was verified by use of various positive
and negative controls as well as another anti-TFF1 antibody
confirming the observations described above (see
Experimental procedures and Figure S1-4).
All experiments indicated that the anti-TFF1 antibody
(Novocastra) was specific. Moreover, our data were supported
by in silico data (Allen Brain Atlas).
Co-localization of TH and TFF1-positive cells in the
developing ventral mesencephalon
To investigate the expression of TFF1 in the SN and VTA
during development we analysed brains from newborn (P0) as
well as post-natal days P7, P14, P21 and adult rats. P0 rats
had very few TFF1-ir cells in the SN/VTA (data not shown),
while numerous TFF1-ir cells were seen in the SN (Figure 4C)
and VTA (not shown) at the other time points. Quantification of
TH-ir cells co-expressing TFF1 in the SN (referring to both SNc
and SNl) revealed that the percentage of TH/TFF1 co-
localization was significantly higher in P7 and P14 rats
compared to P21, whereas there was no significant difference
between P7, P14 and adult or P21 and adult rats (Figure 4B)
Figure 1.  Trefoil factor 1 (TFF1) expression in the midbrain
of adult rats.  Representative photomicrograph depicting the
distribution of TFF1-immunoreactive (-ir) cells in the midbrain
(level: Bregma -5.8 mm). The corresponding schematic
drawing shows the semi-quantitative representation of TFF1-ir
cells in the midbrain. Scale bar: 1 mm.
doi: 10.1371/journal.pone.0076592.g001
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(P7: 32.4 ± 1.6, P14: 33.6 ± 3.3, P21: 24.9 ± 1.5, adult: 26.8 ±
1.5% TH co-localization with TFF1; mean ± SEM; n = 4-7;
P<0.05). In addition, there was no significant difference
between the percentages of TFF1-ir cells co-expressing TH at
any of the time points (Figure 4A) (P7: 87.7 ± 1.8, P14: 84.5 ±
4.7, P21: 88.1 ± 2.5, adult: 89.6 ± 0.9% TFF1 co-localization
with TH; mean ± SEM; n = 4-7).
Phenotypical characterization of TFF1-positive cells in
the ventral mesencephalon
By double immunofluorescence staining we demonstrated
that a high number of the TFF1-ir cells in the SNc, SNl and
VTA co-localized with TH, however, only a subgroup of TH-ir
neurons expressed TFF1 (Figures 2 and 3). Furthermore, a
high number of the TFF1-ir cells co-expressed the calcium-
binding protein calretinin (CR) but few co-expressed calbindin
(CB). As expected by the outcome seen for TFF1 distribution in
the SNr no co-localization was detected for TFF1 and
parvalbumin (PV) (Figure 5).
Double immunofluorescence staining revealed no co-
localization between TFF1 and the astroglial marker GFAP in
the ventral mesencephalon, whereas most of the TFF1-positive
cells co-expressed the pan neuronal marker NeuN (Figure 6).
Given the significant co-localization of TFF1-ir cells with TH-
ir cells we investigated whether TFF1-ir cells in the SN were
projection neurons. For that purpose, the retrograde tracer
Fluorogold (FG) was injected into the right striatum of adult
rats. Two weeks after injection FG was detected in numerous
cells in the SN and a subpopulation of TFF1-ir cells was found
to co-express FG (Figure 7). As expected, a high number of
TH-ir cells co-expressed FG, however, not all TH-ir cells were
found to be FG labelled. To further verify the notion that TFF1-
ir cells may represent dopaminergic projection neurons we
performed immunohistochemical analyses for TFF1 in an
animal model of Parkinson’s disease (PD). As expected, the
SNc was markedly depleted of TH-ir neurons on the lesioned
side, four weeks after a striatal 6-OHDA administration, while
TH-ir cells remained intact in the VTA (Figure 8 A1-2). In
agreement with the outcome of the FG labelling experiments,
we also found decreased numbers of TFF1-ir cells on the
lesioned hemisphere, compared to the non-lesioned
Figure 3.  Quantification of trefoil factor 1 (TFF1) and
tyrosine hydroxylase (TH) co-expressing cells in adult
rats.  Percentage of trefoil factor 1-immunoreactive (TFF1-ir)
cells that co-localized with tyrosine hydroxylase (TH) (A) and
percentage of TH-ir cells that co-localized with TFF1 (B) in the
substantia nigra (SN) and ventral tegmental area (VTA) of adult
rats. *: p<0.05 vs. corresponding VTA values, n = 4.
doi: 10.1371/journal.pone.0076592.g003
Figure 2.  Co-expression of trefoil factor 1 (TFF1) and tyrosine hydroxylase (TH) in the ventral mesencephalon of adult
rats.  Double immunofluorescence staining for TFF1 (red) and TH (green) in the ventral mesencephalon of adult rats. Note that
nearly all TFF1-immunoreactive (-ir) cells co-localized with TH, while many TH-ir cells did not co-express TFF1. Scale bars: 1 mm
(overview); 100 µm (magnification). Abbreviations: SNc, substantia nigra pars compacta; SNl, substantia nigra pars lateralis; VTA,
ventral tegmental area.
doi: 10.1371/journal.pone.0076592.g002
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hemisphere, showing that a significant subpopulation of the
TFF1-ir cells project to the striatum (Figure 8 B1-2).
Discussion
The present study shows for the first time that trefoil factor 1
(TFF1) is markedly expressed in the developing and adult rat
ventral mesencephalon, which is of particular interest in
relation to Parkinson’s disease (PD). TFF1 was detected in a
subpopulation of dopaminergic neurons within substantia nigra
pars compacta (SNc) from postnatal day 7 (P7) to adulthood.
This subgroup of TFF1-immunoreactive (-ir) neurons project to
the striatum as shown by retrograde labelling, as well as by
loss of TFF1-ir cells in the SNc after unilateral, intrastriatal 6-
hydroxydopamine (6-OHDA) injection.
TFF1 expression in adult rat midbrain neurons
TFF1-ir cells were found throughout the adult rat
mesencephalon, but with a distinct distribution pattern, with the
most pronounced expression in the SN, ventral tegmental area
(VTA) and in the periaqueductal grey matter and the Edinger-
Westphal nucleus. These findings suggest that TFF1 might be
involved in a number of complex functions in the midbrain as
the periaqueductal grey plays a role in the descending
Figure 4.  Quantification of trefoil factor 1 (TFF1) and tyrosine hydroxylase (TH) co-expressing cells during
development.  A) Quantification of trefoil factor 1-immunoreactive (TFF1-ir) cells co-expressing tyrosine hydroxylase (TH) and B)
TH-ir cells co-expressing TFF1 in the substantia nigra (SN) of postnatal (P) day 7, 14, 21 and adult rats. The percentage of TH/
TFF1 co-expressing cells was significantly higher for P7 and P14 rats compared to P21 rats, whereas there was no significant
difference between the percentages of TFF1-ir cells co-expressing TH. Data are expressed as mean ± SEM (*: p<0.05, n = 4-7). C)
Representative double immunofluorescence images of TFF1-ir and TH-ir cells in SN of P7, P14 and P21 rats (see Figure 2 for adult
rats). Scale bar: 200 µm.
doi: 10.1371/journal.pone.0076592.g004
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modulation of pain and in defensive behaviour [36]. The
Edinger-Westphal nucleus, also known as the accessory
oculomotor nucleus, contains parasymphatic neurons that
innervate the eye, specifically those that contract the pupil and
adjust the lens [37].
With focus on the ventral mesencephalon, we found that
TFF1 was exclusively expressed in neurons and not in
astrocytes. This was both based on the morphological
appearance of the cells, co-localization with NeuN and the lack
of co-localization with an astroglial marker. Notably, a recent
study has reported that NeuN expression levels in the rat SN
are highly variable, with significant understaining, and that a
substantial number of dopaminergic neurons showed little or no
NeuN expression [38]. This is in line with our observation that a
number of TFF-ir cells did not co-localize with NeuN, and
therefore does not exclude the possibility that these cells are
neurons.
From the few studies of TFF1 in the CNS, astrocytes have
been reported to represent the major site of hippocampal TFF1
mRNA synthesis [27–29]. However, these studies, performed
by a single research group, investigated mRNA levels and no
studies have followed showing protein expression levels.
Nevertheless, such an observation may hint to the hypothesis
of a potential retrograde transport of TFF1 from astrocytes in
the striatum to nigrostriatal dopaminergic neurons. Our finding
of a lack of co-expression for TFF1 and the astroglial marker
GFAP in the striatum, however, does not support this
hypothesis (see Figure S5).
Interestingly, in this context, the recent report by Baydyuk
and co-workers demonstrated that brain-derived neurotrophic
factor and neurotrophin-3 are anterogradely transported from
Figure 5.  Co-expression of trefoil factor 1 (TFF1) and calcium-binding proteins in the ventral mesencephalon of adult
rats.  Double immunofluorescence stainings for TFF1 and the calcium-binding proteins calretinin (CR), calbindin (CB) or
parvalbumin (PV). Note that many TFF1-immunoreactive (-ir) cells co-expressed CR (arrows), but not all CR-ir cells co-localized
with TFF1 (arrowheads). Similarly, co-localization with CB was seen for a few TFF1-ir cells (arrows). As expected from the
distribution pattern depicted in Figure 1 no co-localization was detected for TFF1-ir cells with PV (arrows). Scale bars middle panel:
50 µm, lower panel: 100 µm.
doi: 10.1371/journal.pone.0076592.g005
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midbrain dopaminergic neurons to support the survival of
immature medium-sized spiny neurons in the developing
mouse striatum. They found that striatal neuron numbers
increased between P0 and P21 both in control and
neurotrophin-3 knockout mice, however, the number was
significantly reduced in the neurotrophin-3 knockout mice [39].
Hence, it is tempting to speculate that TFF1 expressing
dopaminergic neurons may provide throphic support to their
target cells. Such an assumption, however, requires additional
experiments and remains speculative at the moment.
Our analyses revealed that TFF1 expression was
predominantly found in SNc and SN pars lateralis (SNl) and to
a lesser extent in the VTA, whereas TFF1 staining was absent
in the SN pars reticulata (SNr). Thus, the staining pattern
resembled that of dopaminergic neurons in these areas. In line
with this notion, double-immunofluorescence analyses revealed
that a high proportion of the TFF1-ir cells co-localized with
tyrosine hydroxylase (TH). In contrast, however, only a
subgroup of TH-ir neurons expressed TFF1. Further evidence
for the existence of dopaminergic TFF1-ir cells in the SN was
provided by FG tracing and intrastriatal injection of the
neurotoxin 6-OHDA. We demonstrated that a subpopulation of
TFF1-ir cells showed co-localization with both TH, and FG
injected into the striatum and retrogradely transported to the
SNc. This observation indicates that these cells are
dopaminergic projection neurons. As expected, a high number
of TH-ir cells in the SNc co-expressed FG, however, not all
were labelled. Since we only applied the FG injection to one
restricted site in the striatum a limited number of dopaminergic
neurons were targeted. Nevertheless, proof that a
subpopulation of TFF1-ir cells are indeed projecting to the
striatum was further substantiated by a marked loss of TFF1-ir
cells in SNc of 6-OHDA-lesioned hemiparkinsonian rats.
However, a more detailed study is necessary to address co-
localization of TH and TFF in the SNc of the lesioned rats.
Hence, we can at present only speculate on the total number of
nigral TFF-ir cells being dopaminergic projection neurons.
The finding that nigral TFF1 expression was found in
calretinin (CR)-ir cells and in some calbindin (CB)-ir cells is
indicative of several subpopulations of dopaminergic TFF-ir
cells. As described previously, the midbrain dopaminergic
neurons can be separated into a dorsal and a ventral tier. The
dorsal tier includes CB-ir cells located in the dorsal part of both
SN and VTA, and some cells of the A8 cell group. The ventral
tier comprises a sheet of more densely packed cells located in
the ventral parts of SN and VTA, which are CB-negative and
are mostly positive for the ion channel protein Girk2 [40,41].
The ventral tier neurons project exclusively to the striatum
where they mainly innervate the patch compartments. The CB-
ir neurons of the dorsal tier constitute a more mixed population,
comprising cells that project not only to limbic and cortical
areas, but also the matrix compartment of the striatum [42,43].
However, future analysis needs to clarify the phenotype of the
TFF1-ir projection neurons.
Taken together, TFF1-ir cells represent a subset of
dopaminergic neurons in the rat ventral mesencephalon, but
Figure 6.  Trefoil factor 1 (TFF1) expression is restricted to neurons.  Representative photomicrographs of double
immunofluorescence stainings for TFF1 and astroglial or neuronal markers in the substantia nigra pars compacta (SNc) of adult
rats. No co-localization was found of TFF1-positive cells (arrows) with the astroglial marker glial fibrillary acid protein (GFAP)
(arrowheads). Notably, a substantial number of the TFF1-ir cells were demonstrated to co-express the pan neuronal marker NeuN
(arrows), while some did not (arrowheads). Scale bar: 50 µm.
doi: 10.1371/journal.pone.0076592.g006
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further evaluation is needed to clarify the specific functions and
characteristics of this subtype in more detail.
TH and TFF1 co-expression during development
Additional analysis of the developmental profile of TFF1
expression in the ventral mesencephalon showed that TFF1
expression was nearly absent in newborn rats (postnatal (P)
day 0), whereas numerous TFF1-ir cells were detected in the
SN and VTA at later developmental stages, i.e. at P7, P14 and
P21. Dopaminergic neurons in the ventral mesencephalon are
generated during a period extending from embryonic (E) day
12 to E16 in rats with a peak of genesis at E13 [44]. Naturally
occurring cell death in the midbrain dopaminergic system starts
shortly before birth in rats with an initial peak at P2 and a
second peak around P14 [45]. During these two periods, TH-ir
cells die by apoptosis, however, little is known about the
specific cell death mechanism [45,46]. Thus, the proliferation
and generation of dopaminergic neurons have stopped before
substantial TFF1 expression appears within the ventral
mesencephalon, hence it seems that TFF1 does not play a role
in the initial generation of dopaminergic neurons. We
hypothesize that TFF1 could be involved in differentiation
and/or survival of dopaminergic neurons. Quantification of co-
expressing cells showed that the percentage of TH-ir cells
expressing TFF1 in the SN was significantly higher in P7 and
P14 rats compared to P21, indicating that a population of the
TH/TFF1 co-expressing cells down-regulate TFF1 or die during
development. However, the percentage of TFF1-ir cells co-
expressing TH (around 85%) was found to be unchanged.
Further investigations are needed to clarify the phenotype of
TFF1 expressing cells and the possible functions of TFF1
during the development and maintenance of dopaminergic
neurons.
Conclusion
In conclusion, TFF1 displays a distinct protein expression
pattern in the developing and adult rat midbrain with marked
expression in a significant subset of dopaminergic projection
neurons in SNc. TFF1 may as such represent a very useful
supplementary marker, but its functional role and whether it
plays a role in the pathophysiology of PD, however, remains to
be elucidated.
Figure 7.  Detection of Trefoil factor 1 (TFF1) in nigrostriatal projection neurons by Fluorogold (FG)
labelling.  Representative photomicrographs of double immunofluorescence stainings for TFF1 and the retrograde tracer FG at the
level of substantia nigra pars compacta (SNc) 10 days after intrastriatal FG injection. A subpopulation of TFF1-ir cells was found to
co-express FG identifying these as projection neurons (arrows). Scale bars upper panel: 100 µm, lower panel: 50 µm.
doi: 10.1371/journal.pone.0076592.g007
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Figure 8.  Loss of trefoil factor 1 (TFF1) expressing cells in a rat model of Parkinson’s disease.  Representative
photomicrographs of tyrosine hydroxylase (TH; A) and TFF1 (B) in brain sections from adult rat ventral mesencephalon at 4 weeks
after unilateral 6-hydroxydopamine (6-OHDA) lesion. The lesion resulted in a distinct loss of TH-ir neurons in right SN (A2) as
compared to the contralateral, unlesioned control side (A1). Similarly, a reduction of TFF1-ir cells was detected on the lesioned side
(B2) as compared to the intact control side (B1). This loss of TFF1-ir cells is better recognized on the enlarged images (B2). Scale
bars: 1 mm (overview), 500 µm (magnification).
doi: 10.1371/journal.pone.0076592.g008
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Supporting Information
Figure S1.  Photomicrographs of sections from the ventral
mesencephalon and stomach of adult rats immunostained
for trefoil factor 1 (TFF1). Control staining was performed by
omitting the primary antibody (-1° ab). Distinct TFF1-
immunoreactive (-ir) cells were found in the adult rat ventral
mesencephalon containing the substantia nigra (SN) as well as
in the gastric tissue (left panel). Moreover, no TFF1 staining
was found in rat SN or gastric tissue when omitting the primary
antibody (right panel). Scale bar: 50 µm.
(TIF)
Figure S2.  Photomicrographs of adult rat brain sections at
the level of the mesencephalon immunostained using
different anti-trefoil factor 1 (TFF1) antibody
concentrations (Novocastra), i.e. 1:250 (A), 1:500 (B),
1:2000 (C). A1, B1 and C1 show a higher magnification of the
substantia nigra pars lateralis. A2, B2, C2 show a higher
magnification of the substantia nigra pars compacta. Note the
different staining pattern of the TFF-ir cells and the difference
in background staining for the different antibody dilutions used.
Scale bars: 1mm (top row); 100 µm (lower rows).
(TIF)
Figure S3.  Photomicrographs of adult rat brain sections
immunostained using mouse monoclonal anti-trefoil factor
1 (TFF1) antibody (Zymed Lab; 1:50; A, C, E) and rabbit
polyclonal anti-TFF1 antibody (Novocastra; 1:1000; B, D,
E). Note the similar staining patterns of TFF1-ir cells seen for
both antibodies at the level of the substantia nigra pars
compacta (SNc), the periaqueductal grey matter (PAG),
including the Edinger-Westphal nucleus (*) (C, D) as well as at
the level of the subfornical organ (SFO) (E, F). Scale bar: 500
µm.
(TIF)
Figure S4.  Photomicrographs of sections through adult
rat ventral mesencephalon at 4 weeks after unilateral 6-
hydroxydopamine (6-OHDA) lesion of the nigrostriatal
pathway immunostained using mouse monoclonal anti-
trefoil factor 1 (TFF1) antibody (Zymed Lab.; 1:50). The
lesion resulted in a distinct loss of tyrosine hydroxylase (TH)-ir
neurons in right SN as compared to the contralateral,
unlesioned control side (see Figure 8). Similarly, a reduction of
TFF1-ir cells was detected on the lesioned side (B) as
compared to the intact control side (A). This loss of TFF1-ir
cells is better recognized on the enlarged images (C, D). Scale
bars: 1 mm (overview), 400 µm (magnification).
(TIF)
Figure S5.  Representative photomicrographs showing a
double-immunofluorescence staining for trefoil factor 1
(TFF1) and the astroglial marker glial fibrillary acidic
protein (GFAP) in the dorsal striatum of adult rats. TFF1-ir
cells (arrows) did not co-localize with GFAP (arrowheads).
Scale bar: 50 µm.
(TIF)
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